C1q nephropathy developing in a case of gastric carcinoma

C1q is a key intermediary in the classical complement pathway. It is known to be activated by several factors including immunoglobulins and charged molecules and is an initiator of the complement cascade. C1q nephropathy (C1qN) is a rare idiopathic glomerulonephritis characterized by predominant presence of glomerular deposits of C1q fraction of complement. Although few uncommon associations of C1qN have been seen with various disorders, we present the first case of C1qN diagnosed in an elderly male with gastric adenocarcinoma. Few months after the onset of symptoms related to gastric-outlet obstruction, the patient presented with oliguria and anasarca. A gastric biopsy revealed a well-differentiated gastric adenocarcinoma, while a renal biopsy showed mesangial hypercellularity with C1q dominant immunofluorescence deposits. The development of C1qN in this case may be a result of the activation of C1q by necrotic or apoptotic cancer cell debris. C1q has been shown to induce apoptosis experimentally in other cancers. The findings suggest a complex role for C1q in initiating tumor apoptosis and subsequent linkage with apoptotic cell products and immunoglobulins to initiate renal damage.

[1]  Z. Bhat,et al.  C1q Nephropathy: The Unique Underrecognized Pathological Entity , 2015, Analytical cellular pathology.

[2]  M. Vankalakunti,et al.  Diverse Clinical and Histology Presentation in C1q Nephropathy , 2013, Nephro-urology monthly.

[3]  A. Cabrita,et al.  C1q nephropathy and malignancy. , 2012, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[4]  M. Wagrowska-Danilewicz,et al.  Nephrotic syndrome and neoplasia: our experience and review of the literature. , 2011, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[5]  M. Ardalan,et al.  C1q Nephropathy in Association with Deforming Arthritis , 2010 .

[6]  Shean-Jen Chen,et al.  Complement C1q Activates Tumor Suppressor WWOX to Induce Apoptosis in Prostate Cancer Cells , 2009, PloS one.

[7]  J. Jennette,et al.  Pathology, clinical presentations, and outcomes of C1q nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[8]  R. Dalton,et al.  C1q nephropathy in association with Gitelman syndrome: a case report , 2006, Pediatric Nephrology.

[9]  M. Daha,et al.  Complement and the kidney: what the nephrologist needs to know in 2006? , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  V. D’Agati,et al.  C1q nephropathy: a variant of focal segmental glomerulosclerosis. , 2003, Kidney international.

[11]  J. Isaac,et al.  De Novo C1q Nephropathy in the Renal Allograft of a Kidney Pancreas Transplant Recipient: BK Virus-Induced Nephropathy? , 2002, Nephron.

[12]  M. Eki̇m,et al.  C1q nephropathy: a case with severe atopic dermatitis , 2002, Pediatric Nephrology.

[13]  S. Iskandar,et al.  C1q nephropathy: a pediatric clinicopathologic study. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.